Neeland IJ et al
Other frequent effects include vomiting, constipation, abdominal pain, and headache, typically occurring during initial treatment or dose increases
Notably, a clinical study demonstrated that T2DM patients receiving insulin therapy experienced significantly higher rates of pancreatitis compared to those treated with GLP-1RAs, and notably, no pancreatitis cases have been reported in clinical trials of the novel GLP-1RA Cotadutide, indicating that a comprehensive risk assessment of GLP-1RAs for pancreatic cancer remains premature pending additional data on these novel medications [8]
Compruebe el nombre, el lote y el documento.
The probiotic guide covers gut health support that helps manage the GI side effects common to this class of medications
If you are particularly sensitive to GLP-1 receptor activation, you might notice very subtle fullness after meals